CSF3 and neutropenia: While earlier studies found that G-CSF prophylaxis for CT-induced neutropenia was underused in European real-world practice [25, 26], more recent studies suggest that the widespread availability and reduced cost of biosimilar G-CSFs are leading to increased use in clinical practice [15, 21, 27].